Literature DB >> 1530753

A consumer's guide to subgroup analyses.

A D Oxman1, G H Guyatt.   

Abstract

The extent to which a clinician should believe and act on the results of subgroup analyses of data from randomized trials or meta-analyses is controversial. Guidelines are provided in this paper for making these decisions. The strength of inference regarding a proposed difference in treatment effect among subgroups is dependent on the magnitude of the difference, the statistical significance of the difference, whether the hypothesis preceded or followed the analysis, whether the subgroup analysis was one of a small number of hypotheses tested, whether the difference was suggested by comparisons within or between studies, the consistency of the difference, and the existence of indirect evidence that supports the difference. Application of these guidelines will assist clinicians in making decisions regarding whether to base a treatment decision on overall results or on the results of a subgroup analysis.

Mesh:

Year:  1992        PMID: 1530753     DOI: 10.7326/0003-4819-116-1-78

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  193 in total

1.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Use of steroids for acute spinal cord injury must be reassessed.

Authors:  D Short
Journal:  BMJ       Date:  2000-11-11

Review 3.  Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

Authors:  N Freemantle
Journal:  BMJ       Date:  2001-04-21

4.  Methylprednisolone for acute spinal cord injury: not a standard of care.

Authors:  Herman Hugenholtz
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

Review 5.  Mirtazapine versus other antidepressive agents for depression.

Authors:  Norio Watanabe; Ichiro M Omori; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 6.  Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Authors:  Morris Zwi; Hannah Jones; Camilla Thorgaard; Ann York; Jane A Dennis
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 7.  Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review.

Authors:  C Meads; C Hyde
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

8.  Systematic reviews of the effectiveness of quality improvement strategies and programmes.

Authors:  J Grimshaw; L M McAuley; L A Bero; R Grilli; A D Oxman; C Ramsay; L Vale; M Zwarenstein
Journal:  Qual Saf Health Care       Date:  2003-08

9.  Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT).

Authors:  Hillary R Bogner; Knashawn H Morales; Edward P Post; Martha L Bruce
Journal:  Diabetes Care       Date:  2007-08-23       Impact factor: 19.112

Review 10.  Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.

Authors:  Janneke P C Grutters; Mark Sculpher; Andrew H Briggs; Johan L Severens; Math J Candel; James E Stahl; Dirk De Ruysscher; Albert Boer; Bram L T Ramaekers; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.